Molina Healthcare financials
$189.38−0.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.76B | $27.72B | $19.36B | $16.71B | $18.89B | $19.88B | $17.78B |
| Gross profit | $5.94B | $6.22B | $5.40B | $4.58B | $4.01B | $3.54B | $2.81B | $3.39B | $2.32B | $2.52B |
| Gross margin | 13.1% | 15.3% | 15.9% | 14.4% | 14.5% | 18.3% | 16.8% | 17.9% | 11.7% | 14.2% |
| Operating income | $781.0M | $1.71B | $1.57B | $955.0M | $968.0M | $1.02B | $929.0M | $1.13B | -$555.0M | $306.0M |
| Net income | $472.0M | $1.18B | $1.09B | $792.0M | $659.0M | $673.0M | $737.0M | $707.0M | -$512.0M | $52.0M |
| Net margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | −2.6% | 0.3% |
| Diluted EPS | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 |
| EBITDA | $976.0M | $1.89B | $1.74B | $1.34B | $1.10B | $1.11B | $1.02B | $1.26B | $327.0M | $488.0M |
| Operating cash flow | -$535.0M | $644.0M | $1.66B | $773.0M | $2.12B | $1.90B | $434.0M | -$314.0M | $804.0M | $673.0M |
| Free cash flow | -$636.0M | $544.0M | $1.58B | $682.0M | $2.04B | $1.82B | $377.0M | -$344.0M | $718.0M | $497.0M |
| Diluted shares | 52.9M | 57.7M | 58.1M | 58.5M | 58.6M | 59.9M | 64.2M | 66.6M | 56.4M | 56.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B |
| Short-term investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B |
| Total debt | $3.95B | $3.12B | $2.38B | $2.39B | $2.39B | $2.35B |
| Total assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B |
| Total liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B |
| Shareholders' equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology